Triple vs. dual therapy in patients with COPD: systematic review and meta-analysis

Introduction: There is uncertainty about the best risk-benefit profile for treatment with triple therapy in patients with COPD. Objective: Identify the available scientific evidence on the effectiveness and safety of triple therapy compared to dual therapy in patients with COPD. Method: A systematic review of the literature was conducted according to the Cochrane methodology using the Medline, Embase and Central databases. Results: Acute exacerbations were evaluated in six studies, rate ratio of 0.74 (0.68-0.81), representing a reduction of 26% and mortality was evaluated in six studies showing a decrease of 29%, relative risk of 0. 71 (0.56-0.91) with triple therapy. Pneumonia was evaluated in seven studies, showing an increase in events with triple therapy, relative risk of 1.54 (1.30-1.81). Adverse events were evaluated in ten studies with no differences found. Discussion: Triple therapy reduced exacerbations and mortality consistent with what was described in previous reviews. Adverse events were similar between both therapies. An increase in pneumonia episodes, a worsening of dyspnea and FEV1 was found with the use of triple therapy . Conclusion: Triple therapy is an important alternative in patients with persistent exacerbations and highly symptomatic despite dual therapy. It is a safe therapy, but the occurrence of pneumonia must be monitored specifically.

Authors

Publication Details

Journal
NCT Neumología y Cirugía de Tórax (English Edition)
Published
2026-11-17
DOI
https://doi.org/10.24875/ncte.m25000037
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Triple vs. dual therapy in patients with COPD: systematic review and meta-analysis

Carolina Ocampo-Salgado, Juan José Yepes-Núñez, Sebastián Castaño-Duque, Diana M. Chaparro-Martínez et al.
2 links
NCT Neumología y Cirugía de Tórax (English Edition)
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Triple vs. dual therapy in patients with COPD: systematic review and meta-analysis

Carolina Ocampo-Salgado, Juan José Yepes-Núñez, Sebastián Castaño-Duque, Diana M. Chaparro-Martínez, Andrés F. Rodríguez-Gutiérrez, Olga M. García-Molares, Jorge E. Rivas-IbarguÓen, Fredy L. Carreño
article en

Abstract

Introduction: There is uncertainty about the best risk-benefit profile for treatment with triple therapy in patients with COPD. Objective: Identify the available scientific evidence on the effectiveness and safety of triple therapy compared to dual therapy in patients with COPD. Method: A systematic review of the literature was conducted according to the Cochrane methodology using the Medline, Embase and Central databases. Results: Acute exacerbations were evaluated in six studies, rate ratio of 0.74 (0.68-0.81), representing a reduction of 26% and mortality was evaluated in six studies showing a decrease of 29%, relative risk of 0. 71 (0.56-0.91) with triple therapy. Pneumonia was evaluated in seven studies, showing an increase in events with triple therapy, relative risk of 1.54 (1.30-1.81). Adverse events were evaluated in ten studies with no differences found. Discussion: Triple therapy reduced exacerbations and mortality consistent with what was described in previous reviews. Adverse events were similar between both therapies. An increase in pneumonia episodes, a worsening of dyspnea and FEV1 was found with the use of triple therapy . Conclusion: Triple therapy is an important alternative in patients with persistent exacerbations and highly symptomatic despite dual therapy. It is a safe therapy, but the occurrence of pneumonia must be monitored specifically.

NCT Neumología y Cirugía de Tórax (English Edition)Vol. 84(3)
Good health and well-being
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon